Carboximidamide derivatives, a process for preparing them and pharmaceutical preparations containing same
申请人:AKZO N.V.
公开号:EP0030749A1
公开(公告)日:1981-06-24
The present invention is dealing with compounds of the formula:
and pharmaceutically acceptable salts thereof, in which n and m represent the number 1 or 2, X and Y hydrogen, alkyl (1-4 C), alkoxy (1-4 C), hydroxy, halogen, hydroxymethyl, trifluoromethyl, acyl (1-4 C), acyloxy (1-4 C) or the group NRx Ry, in whichRx and Ry represent hydrogen, alkyl (1-4 C) or a sulphonyl group and
R represents the group
in which R, and R2 represent hydrogen, alkyl (1-4 C), hydroxy, alkoxy (1-4 C), phenylalkoxy (7-10 C), acyloxy, amino or mono or dialkyl (1-4 C) amino, having potent platelet aggregation inhibiting properties.
本发明涉及如下式的化合物:
及其药学上可接受的盐,其中 n 和 m 代表数字 1 或 2,X 和 Y 代表氢、烷基(1-4 C)、烷氧基(1-4 C)、羟基、卤素、羟甲基、三氟甲基、酰基(1-4 C)、酰氧基(1-4 C)或基团 NRx Ry,其中 Rx 和 Ry 代表氢、烷基(1-4 C)或磺酰基,以及
R 代表以下基团
其中 R 和 R2 代表氢、烷基(1-4 C)、羟基、烷氧基(1-4 C)、苯基烷氧基 (7-10 C)、酰氧基、氨基或单或二烷基(1-4 C)氨基,具有强效血小板聚集抑制特性。